3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| FA-Phe-Ala-OH | 83803-17-2 | |
| Boc-Phe-Phe-Gly-OH | 82816-76-0 | |
| (β-Asp5)-Delta-Sleep Inducing Peptide | 82602-88-8 | |
| FA-Phe-Phe-OH | 83661-95-4 | |
| α-Casein (90-95) | 83471-50-5 | |
| Acetyl-(Ala10·11)-RANTES (1-14) amide (human) | 838825-26-6 | |
| H-Gly-Pro-Ala-OH | 837-83-2 | |
| Monocyte Chemotactic Protein-1 (65-76) (human) | 823814-33-1 | |
| AT-1002 | Gap Junction Protein调节剂 | 835872-35-0 |
| Pyr-Pro-Val-pNA | 83329-36-6 | |
| α-Neoendorphin (1-8) | 83339-89-3 | |
| Tetrapeptide-3 | 四肽-3 | 827306-97-8 |
| Dynorphin B | 猪强啡肽 B | 83335-41-5 |
| ICI 154,129 | 化合物 T22847 | 83420-94-4 |
| Acetyl-(D-Arg10,Cys11,D-Phe14,Cys17)-β-MSH (10-17) amide | 819048-44-7 | |
| Angiotensinogen (1-13)（Human） | 血管紧张素原片段多肽1-13 | 82048-97-3 |
| Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH | 827044-38-2 | |
| Neuropeptide Y (porcine) | 猪源神经肽Y | 82785-45-3 |
| PKG Inhibitor,RKRARKE | PKG 抑制剂H-Arg-Lys-Arg-Ala-Arg-Lys-Glu-OH | 82801-73-8 |
| PTH (1-34) Amide (Human) | 人源甲状旁腺激素多肽PTH (1-34) Amide (Human) | 83139-29-1 |
| Octreotide | 奥曲肽 | 83150-76-9 |
| LF 11 | 脂多糖(LPS)结合区多肽 | 832729-13-2 |
| pTH (28-48) (human) | 甲状腺激素相关肽pTH (28-48) (human) | 83286-22-0 |
| α-Casein (90-96) | 83471-49-2 | |
| Neuropeptide Y (porcine) | 神经肽Y（猪） | 83589-17-7 |
| Acetyl-Phe1-Octreotide | Acetyl-Phe1-奥曲肽杂质 | 83795-61-3 |
| α-CGRP (rat) | 降钙素基因相关肽α-CGRP (rat) | 83651-90-5 |
| H-Pro-Pro-Gln-OH | 856170-98-4 | |
| Neuromedin S (rat) | 鼠源神经介素S Neuromedin S (rat) | 843782-19-4 |
| Pyr-Phe-Leu-pNA | 85901-57-1 | |
| H-Ile-Gly-OH | 868-28-0 | |
| H-Pro-His-Leu-OH | 83960-32-1 | |
| Cdc25A (80-93) (human) | 851538-67-5 | |
| H-Pro-His-Val-OH | 83960-33-2 | |
| Thymopoietin II (32-35) | 胸腺生成素II | 85466-18-8 |
| Pep-1-cysteamide | 863608-35-9 | |
| H-Pro-His-Phe-OH | 83960-34-3 | |
| CRF (human, rat) | 促肾上腺皮质激素释放因子 | 86784-80-7 |
| H-Pro-Pro-Asp-NH2 | 850440-85-6 | |
| Cyclo-Somatostatin | 84211-54-1 | |
| TRAF6 Control Peptide | 852690-80-3 | |
| Bz-Nle-Lys-Arg-Arg-AMC | 863975-32-0 | |
| TRAF6 Peptide | TRAF6特异性抑制剂多肽 | 852805-92-6 |
| H-Ala-Ala-Ala-OMe | L-丙氨酰-L-丙氨酰-L-氨基丙酸甲基酯醋酸盐 | 84794-58-1 |
| (D-Thr2)-Leu-Enkephalin-Thr | 85286-38-0 | |
| AMCA-Glu-Glu-Lys-Pro-Ile-Ser-Phe-Phe-Arg-Leu-Gly-Lys(biotinyl)-NH2 | 851231-19-1 | |
| Ac-a-benzyl-muramyl-Ala-D-Glu(Lys(trans-(3-nitrocinnamoyl))-NH2)-NH2 | 863918-60-9 | |
| Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 | 荧光底物多肽 | 839730-93-7 |
| H-Pro-Asp-OH | 85227-98-1 | |
| Copeptin (rat) | 86280-64-0 | |
| G3-C12 | 结合肽G3-C12 | 848301-94-0 |
| Phospho-Glycogen Synthase Peptide-2 (substrate) | 磷酸糖原合酶肽2（底物） | 851366-97-7 |
| Shepherdin (79-87) | 拟肽拮抗剂多肽Shepherdin (79-87) | 861224-28-4 |
| Acetyl Heptapeptide-4 | 乙酰基七肽-4 | 868844-72-8 |
| Tat-NR2Baa | Tat-NR2B9c对照多肽 | 847829-41-8 |
| MARKSubstrate | MARK底物多肽 | 847991-34-8 |
| Trp3,Arg5]-Ghrelin (1-5) | Trp3,Arg5]-内源性激动剂肽1-5 | 848442-59-1 |
| P11 | 抑制剂多肽P11 | 848644-86-0 |
| Fmoc-Phe-Phe-OH | N-芴甲氧羰基-苯丙氨酰-苯丙氨酸 | 84889-09-8 |
| UFP-101 | 竞争性沉默拮抗剂UFP-101 | 849024-68-6 |
| Dynorphin B (1-13) | 强啡肽 B (1-13) | 85006-82-2 |
| TRH-Gly | 85344-77-0 | |
| Motilin (canine) | 激动剂多肽Motilin, canine | 85490-53-5 |
| Parathyroid Hormone (1-44),human | 人源甲状旁腺激素多肽1-44 | 85568-24-7 |
| Osteocalcin (45-49) (human) | 85679-70-5 | |
| Calcitonin C-Terminal Flanking Peptide (human) | 钙抑肽 | 85916-47-8 |
| H-D-Tyr-Val-Gly-OH | 86030-52-6 | |
| Luteinizing Hormone Releasing Hormone (LH-RH), salmon | 86073-88-3 | |
| M617 | 激动剂多肽M617 | 860790-38-1 |
| Davalintide | 达伐林肽 | 863919-85-1 |
| Polymyxin B nonapeptide | 多粘菌素B九肽 | 86408-36-8 |
| Opiorphin | 864084-88-8 | |
| SALMF amide 1 (S1) | 昆虫神经肽SALMF amide 1 (S1) | 866459-07-6 |
| Tyr34]-pTH (7-34) amide (bovine) | 甲状腺激素相关肽[Tyr34]-pTH (7-34) amide (bovine) | 86292-93-5 |
| c(RGDfC) | RGD肿瘤靶向肽cyclo (Arg-Ala-Asp-d-Phe-Cys) | 862772-11-0 |
| Tyr-Somatostatin-28 | 86649-84-5 | |
| GRF (1-44) (human) | 生长激素释放因子 (1-44) | 83930-13-6 |
| Urotensin I | 硬骨鱼紧张肽 | 83930-33-0 |
| D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P | D-Arg1,D-Pro2,D-Trp7,9,Leu11]神经肽P物质 | 84676-91-5 |
| SCPB | 小心脏活性肽B SCPB | 84746-43-0 |
| Dansyl-D-Ala-Gly-4-nitro-Phe-Gly-OH | 底物多肽N-Dansyl-D-Ala-Gly-p-nitro-Phe-Gly | 83960-27-4 |
| Dynorphin B (1-29) | 强啡肽 B(1-29) | 84376-30-7 |
| Calmodulin Dependent Protein KinaseSubstrate | 钙调素依赖蛋白激酶底物 | 82801-68-1 |
| Peceleganan | 杂化抗菌肽 | 850761-47-6 |
| ZIP | 蛋白激酶抑制剂多肽Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu-OH | 863987-12-6 |
| β-Casomorphin (1-5) amide (bovine) | β-酪啡肽 (1-5) | 83936-21-4 |
| H-Ala-Arg-AMC | 83363-71-7 | |
| Fmoc-Val-Cit-PAB-PNP | 抗体药物偶联物Fmoc-Val-Cit-PAB-PNP | 863971-53-3 |
| Oxytocic acid | Gly9OH]缩宫素；Gly9-OH-缩宫素；杂质F | 848814-27-7 |
| N-(p-Tosyl)-GPR-pNA | N-对甲苯磺酰基-甘氨酰-脯氨酰-精氨酰对硝基苯胺 | 86890-95-1 |
| Peptide YY (13-36) (canine, mouse, porcine, rat) | 酪酪肽片段多肽Peptide YY (13-36) (canine, mouse, porcine, rat) | 86895-09-2 |
| D-Pro4,D-Trp7,9,10]-Substance P (4-11) | D-Pro4,D-Trp7,9,10]-神经肽P物质4-11 | 86917-57-9 |
| Acetyl Octapeptide-3 | 八胜肽；乙酰基八肽-3 | 868844-74-0 |
| C(RGDfK(N3)) | RGD-叠氮环肽 | 868845-09-4 |
| (D-Pro4,D-Trp7.9.10,Val8)-Substance P (4-11) | 86917-56-8 | |
| Fmoc-Gly-Val-OH | 86895-14-9 | |
| (2S)-beta-Alanyl-L-prolyl-2 | 类蛇毒三胜肽 | 823202-99-9 |
| Linaclotide | 利拉洛肽 | 851199-59-2 |
| Acetyl tetrapeptide-3 | 乙酰基四肽-3 | 827306-88-7 |
| Acetyl Tetrapeptide-5 | 乙酰基四肽-5 |
联系方式
